• Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
  
• Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
  

PubMed=9924699; DOI=10.1097/00002371-199901000-00007
Stefan Sleijfer, T.K. Phuong Le, Steven de Jong, Hetty Timmer-Bosscha, Sebo Withoff, Nanno H. Mulder;
Combined cytotoxic effects of tumor necrosis factor-alpha with various cytotoxic agents in tumor cell lines that are drug resistant due to mutated p53.
J. Immunother. 22:48-53(1999)

PubMed=12093475; DOI=10.1016/S0006-2952(02)00983-8
Eelco Fokkema, Harry J.M. Groen, Marco N. Helder, Elisabeth Geertruida Emma de Vries, Coby Meijer;
JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
Biochem. Pharmacol. 63:1989-1996(2002)